Candel Therapeutics (CADL) EPS (Basic) (2020 - 2025)
Candel Therapeutics (CADL) reported EPS (Basic) of -$0.29 for Q4 2025, down 14.62% on a YoY basis from -$0.34 in Q4 2024, and up 33.26% sequentially from -$0.43 in Q3 2025.
Candel Therapeutics (CADL) EPS (Basic) (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of EPS (Basic) data on file, last reported at -$0.29 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) fell 14.62% year-over-year to -$0.29; the trailing twelve-month figure through Dec 2025 stood at -$1.54 (up 31.11% YoY), and the FY2025 full-year result was -$2.07, down 9.49% from the prior year.
- EPS (Basic) grew to -$0.29 in Q4 2025, from -$0.43 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.25 in Q4 2024 to a low of -$1.38 in Q4 2021.
- A 5-year average of -$0.52 and a median of -$0.38 in 2021 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 78.61% in 2022, while the deepest fall reached 231.74% in 2022.
- Tracing CADL's EPS (Basic) over 5 years: stood at -$1.38 in 2021, then surged by 78.61% to -$0.3 in 2022, then slipped by 22.3% to -$0.36 in 2023, then jumped by 30.6% to -$0.25 in 2024, then declined by 14.62% to -$0.29 in 2025.
- Business Quant data shows CADL's EPS (Basic) at -$0.29 in Q4 2025, -$0.43 in Q3 2025, and -$0.42 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Candel Therapeutics | 504.70 Mn | 504.70 Mn | - | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -0.42 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.90 |
| Jun 30, 2024 | -0.86 |
| Mar 31, 2024 | -0.28 |
| Dec 31, 2023 | -0.36 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.35 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -1.33 |
| Dec 31, 2021 | -1.38 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.45 |
| Mar 31, 2021 | -0.40 |